Showing results (131-140 of 271) with videos related to
Sort By:
Pageof 28
Current Opinion in Cardiology|June 6, 2013
New therapies to reduce low-density lipoprotein cholesterolAnthony S Wierzbicki, Adie Viljoen, Timothy C Hardman, et al.The American Journal of Cardiology|February 13, 2001
Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemiaA S Wierzbicki, P J Lumb, G Chik, et al.Current Pharmaceutical Design|December 7, 2010
Sodium-glucose co-transporter 2 inhibitors: from apple tree to 'Sweet Pee'Timothy C Hardman, Peter Rutherford, Simon W Dubrey, et al.Orphanet Journal of Rare Diseases|September 21, 2017
The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative studySasi Neelamekam, See Kwok, Rachel Malone, et al.Current Opinion in Cardiology|May 7, 2009
Lipoprotein a: where are we now?Konstantinos Tziomalos, Vasilios G Athyros, Anthony S Wierzbicki, et al.Current Opinion in Cardiology|June 4, 2008
Multiple actions of high-density lipoproteinMatilda Florentin, Evangelos N Liberopoulos, Anthony S Wierzbicki, et al.International Journal of Clinical Practice|February 29, 2000
Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemiaA S Wierzbicki, P J Lumb, G Chik, et al.Journal of Clinical Pathology|February 1, 1990
Effect of haemolysate preparation on measurement of red cell folate by a radioisotopic methodC R Gilois, J Stone, A P Lai, et al.Die Nahrung|January 1, 1983
Sensory effect of the sorption of some flavouring agents on blood plasma protein preparationsW Uchman, S Wierzbicki, P Smigielski, et al.Journal of Clinical Pathology|December 24, 2008
The copper/caeruloplasmin ratio in routine clinical practice in different laboratoriesP J Twomey, A S Wierzbicki, T M Reynolds, et al.Pageof 28